Pathoanatomy of Parkinson's disease - PubMed (original) (raw)
Review
. 2000 Apr:247 Suppl 2:II3-10.
doi: 10.1007/PL00007758.
Affiliations
- PMID: 10991663
- DOI: 10.1007/PL00007758
Review
Pathoanatomy of Parkinson's disease
H Braak et al. J Neurol. 2000 Apr.
Abstract
Parkinson's disease is a widespread degenerative illness affecting the human central, peripheral, and enteric nervous systems. The underlying pathological process progresses slowly but relentlessly and involves multiple neuronal systems. The disease is the consequence of changes in the neuronal cytoskeleton developing in only a few susceptible types of nerve cells. Afflicted neurons eventually produce Lewy bodies in their perikarya and Lewy neurites in their neuronal processes. Immunoreactions against the presynaptic protein alpha-synuclein have revealed many kinds of inclusion bodies ranging from inconspicuous dot- or thread-like forms to particularly voluminous types. The selective vulnerability of nerve cells induces a distinctive distribution pattern of lesions which remains remarkably consistent across cases. Components of the limbic system and the motor system have been shown to be particularly vulnerable to severe destruction. Some subnuclei of the substantia nigra also undergo major changes. This damage is consistently accompanied by extranigral alterations, with predilection sites including the entorhinal region, the second sector of the Ammon's horn, and important subnuclei of the amygdala. In addition, the nucleus of the stria terminalis, components of the hypothalamus, all of the non-thalamic nuclei with diffuse projections to the cerebral cortex, and most of the centers regulating autonomic functions exhibit severe lesions.
Similar articles
- Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J. Braak H, et al. J Neural Transm (Vienna). 1996;103(4):455-90. doi: 10.1007/BF01276421. J Neural Transm (Vienna). 1996. PMID: 9617789 Review. - Nigral and extranigral pathology in Parkinson's disease.
Braak H, Braak E, Yilmazer D, Schultz C, de Vos RA, Jansen EN. Braak H, et al. J Neural Transm Suppl. 1995;46:15-31. J Neural Transm Suppl. 1995. PMID: 8821039 Review. - [Postmortal diagnosis of Parkinson's disease].
Sandmann-Keil D, Braak H. Sandmann-Keil D, et al. Pathologe. 2005 May;26(3):214-20. doi: 10.1007/s00292-004-0722-5. Pathologe. 2005. PMID: 15538572 Review. German. - Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system.
Braak H, Rüb U, Sandmann-Keil D, Gai WP, de Vos RA, Jansen Steur EN, Arai K, Braak E. Braak H, et al. Acta Neuropathol. 2000 May;99(5):489-95. doi: 10.1007/s004010051150. Acta Neuropathol. 2000. PMID: 10805091
Cited by
- Neuroimaging Biomarkers in Parkinson's Disease.
Holmes S, Tinaz S. Holmes S, et al. Adv Neurobiol. 2024;40:617-663. doi: 10.1007/978-3-031-69491-2_21. Adv Neurobiol. 2024. PMID: 39562459 - Functional activity, functional connectivity and complex network biomarkers of progressive hyposmia Parkinson's disease with no cognitive impairment: evidences from resting-state fMRI study.
Geng L, Cao W, Zuo J, Yan H, Wan J, Sun Y, Wang N. Geng L, et al. Front Aging Neurosci. 2024 Sep 25;16:1455020. doi: 10.3389/fnagi.2024.1455020. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39385833 Free PMC article. - Prospective Study of Lung Function with Prodromal, Clinical Parkinson's Disease, and Mortality.
Chen X, Zhang Z, Tong L, Wang H, Xu X, Sun L, Li Y, Gao X. Chen X, et al. J Parkinsons Dis. 2024;14(7):1427-1439. doi: 10.3233/JPD-240097. J Parkinsons Dis. 2024. PMID: 39269854 Free PMC article. - Poly(acrylic acid)/Poly(vinyl alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies.
Li Y, Vora LK, Wang J, Sabri AHB, Graham A, McCarthy HO, Donnelly RF. Li Y, et al. Pharmaceutics. 2024 May 17;16(5):676. doi: 10.3390/pharmaceutics16050676. Pharmaceutics. 2024. PMID: 38794339 Free PMC article. - Tango and physiotherapy interventions in Parkinson's disease: a pilot study on efficacy outcomes on motor and cognitive skills.
Rabini G, Meli C, Prodomi G, Speranza C, Anzini F, Funghi G, Pierotti E, Saviola F, Fumagalli GG, Di Giacopo R, Malaguti MC, Jovicich J, Dodich A, Papagno C, Turella L. Rabini G, et al. Sci Rep. 2024 May 24;14(1):11855. doi: 10.1038/s41598-024-62786-6. Sci Rep. 2024. PMID: 38789492 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical